Mark Tarr - 30 Apr 2024 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: President & CEO, Director
Signature: /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr
Issuer symbol: EHC
Transactions as of: 30 Apr 2024
Transactions value $: -$2,306,405
Form type: 4
Filing time: 01 May 2024, 11:47:42 UTC
Previous filing: 04 Mar 2024
Next filing: 03 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHC	Encompass Health Common Stock	Options Exercise	$697K	+19.5K	+3.51%	$35.83	574K	30 Apr 2024	Direct
transaction	EHC	Encompass Health Common Stock	Options Exercise	$741K	+25.5K	+4.45%	$29.06	599K	30 Apr 2024	Direct
transaction	EHC	Encompass Health Common Stock	Sale	-$3.75M	-45K	-7.51%	$83.27	554K	30 Apr 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-19.5K	-100%	$0.00^*	0	30 Apr 2024	Encompass Health Common Stock	19.5K	$35.83	Direct	F2
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-25.5K	-100%	$0.00^*	0	30 Apr 2024	Encompass Health Common Stock	25.5K	$29.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F2	The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

Content

This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.